The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.40
Ask: 40.00
Change: -1.60 (-3.87%)
Spread: 0.60 (1.523%)
Open: 41.30
High: 41.30
Low: 39.55
Prev. Close: 41.30
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING: Zambeef sees profit above market views; Luceco trades in line

Tue, 07th Nov 2023 17:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Luceco PLC - London-based lighting manufacturer and distributor - Says that in the three months ended September 30, it traded in line with expectations. Revenue in the third quarter was 8.3% ahead of the prior year. Looking ahead, Luceco left its full-year guidance unchanged. Chief Executive Officer John Hornby says: "Whilst demand from energy saving professional projects continues its positive path; we are seeing some impact of reduced demand in certain of our end markets as the UK consumer continues to experience economic headwinds. Luceco's strong cash generation in the quarter was particularly encouraging, and with our low levels of net debt, the group is well placed to invest in growth and enhance earnings in line with strategic priorities."

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Further expands partnership with M8 Pharmaceuticals Inc. Says M8 has taken up its rights to extend its licensing agreement from Brazil and Mexico to market MED3000 in a further fourteen countries throughout the Central and South American region. Futura has received an undisclosed upfront milestone payment from M8 as part of the extended agreement. The extension builds on the agreement signed in August 2021. Apart from the geographic expansion, the commercial terms and initial duration of the agreement remain unchanged. CEO James Barder says: "This is another major step forward in the execution of Futura's strategy. M8 is an excellent partner with dedicated brand-building and marketing experience, as well as scale and strong pharmaceutical connections in South and Central America and we look forward to working closely with them across the Latin American region."

----------

Vianet Group PLC - Stockton-on-Tees, England-based provider of retail sales and volume monitoring systems - Intends to conduct on-market purchases under a share buyback programme. The programme, which will be funded from its existing cash resources, is intended to reduce the share capital of the company. The buyback will begin immediately and will close at the conclusion of the 2024 annual general meeting, or September 5.

----------

Scotgold Resources Ltd - Stirlingshire, Scotland-based gold and silver exploration company's- Says it is considering the appointment of administrators "over the coming days." In October, Scotgold said it was in "advanced" financing discussions with a strategic investor, but now says the discussions "have not resulted in an investment at this time." Its share were suspended in September, pending clarification of its financial position.

----------

Zambeef Products PLC - Lusaka-based cold chain foods and retail business with operations in Zambia, Nigeria and Ghana - Says forward guidance on financial trading performance for the year ended September 30 is expected to be above market expectations, despite a challenging operating environment. Says revenue, gross profit and adjusted earnings before interest, tax, depreciation and amortisation are expected to be between 5-15% higher than market expectations. Reported pretax profit is expected to be about 30% higher than current market expectations. "The group continued to see increasing demand for its products, supported by a price moderation approach, resulting in volume growth across most product categories. Lower than expected selling prices and higher input costs (which couldn't fully be passed on to the consumer), including fuel and electricity, put pressure on gross margins which moderated in the second half," it says.

----------

F&C Investment Trust PLC - aims for long-term growth and income by investing in listed equities globally - Says that a third dividend for 2023 will be paid. Ups quarterly dividend to 3.40p from 3.20p a year earlier. Looking ahead, F&C plans to deliver another rise in our total dividend for this year, which will be the 53rd consecutive annual rise.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
4 Aug 2020 12:57

Futura Medical upbeat on cannabidiol gel lab work

(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of initial laboratory and optimisation work on a 'Dermasys' cannabidiol gel, dubbed 'CBD100', under the joint venture collaboration agreement with CBDerma Technology that was announced in September.

Read more
14 Jul 2020 21:51

IN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation

IN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation

Read more
24 Jun 2020 11:45

Futura Medical Reports Limited Impact Of Covid-19 On Its Operations

Futura Medical Reports Limited Impact Of Covid-19 On Its Operations

Read more
24 Jun 2020 11:06

Futura makes good progress with topical erectile dysfunction treatment

(Sharecast News) - Futura Medical updated the market on Wednesday, reporting that the impact of the Covid-19 pandemic on the company had been "limited" to date.

Read more
18 Jun 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2020 09:45

UK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight

UK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight

Read more
20 Apr 2020 16:09

Futura files for second FDA meeting over erection gel

(Sharecast News) - Futura Medical has filed for a further pre-submission meeting with the US Food and Drug Administration (FDA), it announced on Monday, following receipt of the complete and signed clinical study report for its phase 3 Study, 'FM57'.

Read more
20 Apr 2020 13:24

Futura Files For Erectile Dysfunction Treatment Pre-Submission Meeting

Futura Files For Erectile Dysfunction Treatment Pre-Submission Meeting

Read more
1 Apr 2020 11:10

Futura Optimistic Over Approvals For Erectile Dysfunction Treatment

Futura Optimistic Over Approvals For Erectile Dysfunction Treatment

Read more
25 Mar 2020 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
13 Feb 2020 18:33

Futura Pursues Regulatory Approval For Erectile Dysfunction Treatment

Futura Pursues Regulatory Approval For Erectile Dysfunction Treatment

Read more
10 Jan 2020 16:10

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
23 Dec 2019 09:53

Futura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier

Futura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier

Read more
20 Dec 2019 16:53

Futura Medical To Raise GBP3.3 Million In Shares After Test Failure

Futura Medical To Raise GBP3.3 Million In Shares After Test Failure

Read more
10 Dec 2019 13:54

Futura Medical Erectile Dysfuction Drug MED2005 Fails To Beat Placebo

Futura Medical Erectile Dysfuction Drug MED2005 Fails To Beat Placebo

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.